mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |